[Treatment of idiopathic hypercalcemia].
D002116:Calcitonin / Q000008:administration & dosage / Q000494:pharmacology; D002118:Calcium / Q000032:analysis / Q000378:metabolism; D002664:Child Nutritional Physiological Phenomena; D004035:Diet Therapy; D004492:Edetic Acid / Q000627:therapeutic use; D004794:Enzyme Repression; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000628:therapy*; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007408:Intestinal Absorption; D007475:Ion Exchange Resins / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014807:Vitamin D / Q000008:administration & dosage
D005938:Glucocorticoids; D007475:Ion Exchange Resins; D010710:Phosphates; D013431:Sulfates; D014807:Vitamin D; D002116:Calcitonin; D004492:Edetic Acid; D013974:Thyroxine; D002118:Calcium
Traitement de l'hypercalcemie idiopathique.